InvestorsHub Logo
Followers 74
Posts 11219
Boards Moderated 2
Alias Born 02/13/2014

Re: None

Monday, 09/04/2023 11:52:36 AM

Monday, September 04, 2023 11:52:36 AM

Post# of 324
From the article below:

“In February 2023, Revive Therapeutics Ltd. entered into a research collaboration agreement with PharmaTher Holdings Ltd. to evaluate the delivery of 3,4-Methylenedioxymethamphetamine ("MDMA") using PharmaTher's novel microneedle patch ("MN-Patch") delivery technology. The MDMA MN-Patch enables flexible drug load capacity and combinations, controlled released delivery, and the ability to present desired pharmacokinetic and safety profiles, overcoming the potential obstacles of oral dosing.”